|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin:results of the GALIANT trial--a primary care,type 2 diabetes study显示文摘 | Blonde L Dagogo-Jack S Banerji MA | | 0，，： | 1 |
| 2 | American Association of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan显示文摘 | Handelsman Y Mechanick JI Blonde L | 2011 | Endocr Pract2011，17，2： | 1 |
| 3 | Road maps to achieve glycemic control in type 2 daiabetes mellitus: ACE/ AACE Diabetes Road Map Task Force 显示文摘 | Davidson JA Blonde L Jellinger PS | 2007 | Endocr Pract2007，13，3： | 1 |
| 4 | Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes : results of a 6-month, randomized, comparative trial 显示文摘 | Hollander PA Blonde L Rowe R | 2004 | Diabetes Care2004，27，10： | 1 |
| 5 | The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes : An overview of the LEAD 1-5 studies 显示文摘 | Blonde L Russell-Jones D | 2009 | Diabetes Obes Metab2009，11，3： | 1 |
| 6 | The safety and efficacy of liraglutide with or without oral antidiabetic drugtherapy in type 2 diabetes: an overview of the LEAD 1-5 studies显示文摘 | Blonde L Russell-Jones D | 2009 | Diabetes Obes Metab2009，11，3： | 1 |
| 7 | American association of clinical endocrinologists medical guidelines for clinical practice for the mana~gement of diabetes mellitus显示文摘 | Rodbard HW Blonde L Braithwaite SS | 2007 | Endocr Pract2007，13，1： | 1 |
| 8 | Durable efficacy of mefformin/glibenclamide combination tablets (Gluco- vance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previ-ous sulphonylurea monotherapy 显示文摘 | Blonde L Joyal S Henry D | 2004 | Int J Clin Pract2004，58，9： | 1 |
| 9 | Interim analysis of the effects ofexenatide treatment on Ale, weight and cardiovascular risk factors over82 weeks in 314 overweight patients with type 2 diabetes显示文摘 | Blonde L Klein EJ Han J | 2006 | Diabetes Obesity and Metabolism2006，8，4： | 1 |
| 10 | Ventroposteroventral pallidotomy can abolish all Parkinsonian sympotoms显示文摘 | LAITINEN L V BLOND S | 1992 | Stereotact Funct Neurosurg1992，58，1： | 1 |
| 11 | Interim analysis of flie effects of exenatidetreatment on A1C, weight and cardiovascular risk factors over 82 weeksin 314 overweight patients with type 2 diabetes显示文摘 | Blonde L Klein EJ Han J | 2006 | Diabetes Obes Metab2006，8，： | 1 |
| 12 | The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations显示文摘 | Garber AJ Blonde L Bloomgarden ZT | | 0，，01： | 1 |
| 13 | Efficacy and safety of inhaled insulin(Exubera)compared with subcutaneous insulin therapy in patients with type 2 diabetes:results of a6month,randomized,comparative trial显示文摘 | Hollander PA Blonde L Rowe R | 2004 | Diabetes Care2004，27，10： | 1 |
| 14 | American assocoation of clinical endocrinologists medical guidelines for clinical practice for the mangement of diabetes mellitus 显示文摘 | Rodbard HW Blonde L Braithwaite SS | 2007 | Endocr Pract2007，13，1： | 1 |
| 15 | Interim analysis of the effects of exenatide treatment on A1C,weight and cardiovascular risk factors over 82 weeks in 314overweight patients with type 2 diabetes显示文摘 | Blonde L Klein EJ Han J | 2006 | Diabetes Obesity and Metabolism2006，8，4： | 1 |
| 16 | The arthroscopic deepening trochleoplasty显示文摘 | Blond L Schottle B | 2010 | Knee Surg Sports Traumatol Arthrosc2010，18，4： | 1 |
| 17 | An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor显示文摘 | BLOND J L LAVILLETTE D CHEYNET V | 2000 | J Virol2000，74，： | 1 |
| 18 | Greater reductions in A1C intype 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin显示文摘 | Wogen J Kreilick C | 2003 | Diabe Obes Metab2003，5，6： | 1 |
| 19 | Efficacy and safety of inhaled insulin (exubera)compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6 month, randomized, comparative trial 显示文摘 | Hollander PA Blonde L Rowe R | 2004 | Diabetes Care2004，27，10： | 1 |
| 20 | Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes:results of a 6-month,randomized,comparative trial显示文摘 | HOLLANDER P A BLONDE L ROWE R | 2004 | Diabetes Care2004，27，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员